Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal for Immunotherapy of Cancer|September 15, 2019
Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapyXiang-Min Tong, Liang Feng, Sreedhar Reddy Suthe, et al.Acta Pharmacologica Sinica|January 21, 2025
Humanized dual-targeting antibody-drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneityMinghai Wang, Qi Ma, Sreedhar Reddy Suthe, et al.The Journal of Investigative Dermatology|February 8, 2018
A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant AcneSumana Ghosh, Mau Sinha, Anamika Bhattacharyya, et al.Molecular Pharmaceutics|June 27, 2018
Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine KinaseHang-Ping Yao, Liang Feng, Tian-Hao Weng, et al.Journal for Immunotherapy of Cancer|April 4, 2019
Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapyHang-Ping Yao, Liang Feng, Sreedhar Reddy Suthe, et al.Journal for Immunotherapy of Cancer|March 16, 2019
Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapyHang-Ping Yao, Liang Feng, Sreedhar Reddy Suthe, et al.Clinical Transplantation|July 13, 2021
A retrospective multi-center experience of renal transplants from India during COVID-19 pandemicPranaw Kumar Jha, Dinesh Kumar Yadav, Vishwanath Siddini, et al.Cell Reports|November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capabilityYang Feng, Jaewon Lee, Liping Yang, et al.Pageof 5